Single Blinded First CMC Osteoarthritis Treatment
Not Applicable
Recruiting
- Conditions
- Osteoarthritis Thumb
- Interventions
- Drug: Platelet ConcentrateDrug: Corticosteroid injectionOther: Normal Saline
- Registration Number
- NCT03196310
- Lead Sponsor
- Kettering Health Network
- Brief Summary
Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- Stage 1-3 osteoarthritis of the basal joint
Exclusion Criteria
- Patients with Stage 4 1st carpometacarpal joint arthritis as described by Eaton
- Patients who have received a corticosteroid injection in the last year to the 1st CMC joint on the proposed study side
- Patients who have scaphotriquetral, radioscaphoid, or scaphotrapezial osteoarthritis
- Patients who have concurrent DeQuervain's tenosynovitis or intersection syndrome or have been treated for either of these in the last 3 months
- Patients undergoing evaluation of cervical radiculopathy
- Patients with fibromyalgia or inflammatory rheumatic disease
- Patients with Pressier disease, Kienbock's, or avascular necrosis of the scaphoid
- Patients with any history of primary or secondary bone tumor
- Patients that are pregnant or terminally ill
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description PRP Platelet Concentrate Intra-articular injection of platelet rich plasma. Corticosteroid Corticosteroid injection Intra-articular injection of kenalog. Normal Saline Normal Saline Intra-articular injection of normal saline
- Primary Outcome Measures
Name Time Method Disabilities arm shoulder and hand score 1 year functional score
- Secondary Outcome Measures
Name Time Method Pinch Strength 1 year Objective measurement
Trial Locations
- Locations (1)
Orthopedic Associates of Southwest Ohio
🇺🇸Centerville, Ohio, United States